Cells treated with the acetylcholinesterase inhibitor donepezil, used clinically in the treatment of AD, also showed reduced glutamate NMDAR mediated Ca2+ influx, an effect which was blocked by an α7nAChR antagonist [100]. This evidence concerns the gene CHRNA7 and Alzheimer disease.